Arbutus Biopharma(ABUS)
Search documents
Arbutus Biopharma(ABUS) - 2022 Q1 - Earnings Call Transcript
2022-05-05 18:05
Arbutus Biopharma Corp, Inc. (NASDAQ:ABUS) Q1 2022 Earnings Conference Call May 5, 2022 8:45 AM ET Company Participants Lisa Caperelli - VP, IR William Collier - President, CEO & Director Michael Sofia - Chief Scientific Officer David Hastings - CFO & CAO Gaston Picchio - Chief Development Officer Conference Call Participants Douglas Buchanan - JMP Securities Yuchen Ding - Jefferies Thomas Yip - H.C. Wainwright & Co. Luke Herrmann - Robert W. Baird & Co. Keay Nakae - Chardan Capital Markets Operator Good da ...
Arbutus Biopharma(ABUS) - 2021 Q4 - Earnings Call Transcript
2022-03-03 19:31
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2021 Earnings Conference Call March 3, 2022 8:45 AM ET Company Participants Lisa Caperelli - Vice President, Investor Relations William Collier - President and Chief Executive Officer David Hastings - Chief Financial Officer Gaston Picchio - Chief Development Officer Michael Sofia - Chief Scientific Officer Conference Call Participants Roy Buchanan - JMP Securities Dennis Ding - Jefferies Ed Arce - H.C. Wainwright Brian Skorney - Baird Operator Good day and th ...
Arbutus Biopharma(ABUS) - 2021 Q3 - Earnings Call Transcript
2021-11-04 18:15
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q3 2021 Earnings Conference Call November 4, 2021 8:45 AM ET Company Participants Lisa Caperelli - Vice President or Investor Relations Bill Collier - President and Chief Executive Officer Dave Hastings - Chief Financial Officer Gaston Picchio - Chief Development Officer Mike Sofia - Chief Scientific Officer Conference Call Participants Roy Buchanan - JMP Securities Luke Herrmann - Baird Ed Arce - H.C. Wainwright & Company Keay Nakae - Chardan Kelechi Chikere - Je ...
Arbutus Biopharma(ABUS) - 2021 Q2 - Earnings Call Transcript
2021-08-05 19:06
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q2 2021 Earnings Conference Call August 5, 2021 8:15 AM ET Company Participants Pam Murphy - IR Bill Collier - President, CEO Dave Hastings - CFO Gaston Picchio - CDO Mike Sofia - CSO Conference Call Participants Roy Buchanan - JMP Securities Keay Nakae - Chardan Kelechi Chikere - Jefferies Operator Good day, and thank you for standing by. Welcome to the Arbutus Biopharma Corporation 2021 Second Quarter Financial Results and Corporate Update Conference Call. At th ...